Wikipedia -WSS

Wikipedia

author：comprehensive 2025-10-01 11:43:55 - browse：34624

Eli Lilly headquarters — Kristoffer Tripplaar/AP

Eventually, the luckiest companies get to deal with a very particular problem: what to do when their stock could be getting ahead of itself.

It’s a problem Eli Lilly got a little taste of Tuesday when it announced its full-year earnings. The drugmaker’s stock has more than doubled over the past 12 months due to the ever-increasing hopes for its GLP-1-based diabetes and weight loss drug, sold under the brand names Mounjaro and Zepbound. It was a big deal when Lilly became the first drug company ever to have a market value of $500 billion; it’s now sitting at a stunning $670 billion.

At first, the earnings report suggested the company had blasted through expectations again, announcing fourth-quarter 2023 sales of $9.35 billion, almost half a billion dollars above analysts’ expectations, and also announcing new data for Mounjaro in treating metabolic dysfunction-associated steatohepatitis (MASH), a form of liver disease previously called NASH. Initially, shares traded up 5%.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： United colonoscopy coverage change 'may cost lives,' doctors say
Next article： Wegovy improves function in certain heart failure patients

hotspot

Wikipedia

WSS

CDC says it’s too soon to assess risk posed by Covid subvariant

Ukraine and a new approach to mental health in war

Intarcia’s device

How to make over

Intarcia’s device

AstraZeneca, Daiichi breast cancer treatment succeeds in trial

focus

Wikipedia

focus

In Memoriam: Notable people who died in 2023

How to make over

Sports medicine is finally prioritizing gender equality

Health officials lay out plans to cope with respiratory virus season

DIEP, the 'gold standard' of breast reconstruction, is under threat

Can U.S. cancer drug shortages be fixed?

State Dept. review finds Biden bears some blame for Afghanistan failures

People can get long Covid without testing positive for virus: Study

FDA approval of Sarepta Duchenne genetic therapy gives me hope

DeSantis wants to import drugs. Biden’s FDA blasted his plan

focus

Intellia plays down concerns on accidental germline transmission

Senators: Long

Ukraine and a new approach to mental health in war

It's been 20 years since Dolly the sheep. Where's my clone?

Former Pear Therapeutics executives start new VC firm

Lasker Awards 2023: Winners in biomedical research

hotspot

Wikipedia

explore

hotspot